Jim Cramer's daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio.
Jim Cramer 's daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Oracle : The tech giant had a mixed quarter. But it announced new artificial intelligence partnerships with Alphabet 's Google and Microsoft -backed OpenAI. Oracle also reported strong RPO, short for remaining performance obligation. RPO is what contracted customers are expected to pay in the future and the backlog of business.
"This is a momentum stock so it's not necessarily going to give up the ghost here," Cramer said. "But it is expensive versus its cohorts." Johnson & Johnson : The company reached a $700 million settlement with states over the marketing of its talc-based baby powder. This is a positive, Cramer said. But he added that J & J is a health-care staple stock and it's not going to run here.
Health Care Industry Pharmaceuticals Retail Industry Breaking News: Business Technology Breaking News: Technology Casey's General Stores Inc Paramount Global Johnson & Johnson Birkenstock Holding PLC Oracle Corp Morningmeetingrapid Stock Takes Jim Cramer Investment Strategy Markets Breaking News: Markets Investingclubsample Regwall-Investingclub Alphabet Inc Microsoft Corp Business News
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Jim Cramer: Warren Buffett's former mystery stock Chubb is still really cheap and going higher'This stock is going much higher,' CNBC's Jim Cramer said Friday.
Read more »
Cramer explains why Apple's conference made him more bullish on the stockCNBC's Jim Cramer reviewed what Apple revealed at its Worldwide Developers Conference on Monday.
Read more »
Cramer explains why Apple's conference made him more bullish on the stockCNBC’s Jim Cramer reviewed what Apple revealed at its Worldwide Developers Conference on Monday.
Read more »
Cramer explains why Apple's conference made him more bullish on the stockCNBC’s Jim Cramer reviewed what Apple revealed at its Worldwide Developers Conference on Monday.
Read more »
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030AstraZeneca CEO Pascal Soriot discussed his company’s ambitious revenue goal with CNBC’s Jim Cramer.
Read more »
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030AstraZeneca CEO Pascal Soriot discussed his company’s ambitious revenue goal with CNBC’s Jim Cramer.
Read more »